1-oleoyl-2-docosahexaenoyl phosphatidylcholine: increases paradoxical sleep in rats; structure given in first source; RN given refers to (Z)-isomer; RN for cpd without isomeric designation not available 12/93
ID Source | ID |
---|---|
PubMed CID | 6438829 |
MeSH ID | M0224068 |
Synonym |
---|
1-oleoyl-2-docosahexaenoyl phosphatidylcholine |
[(2r)-2-[(4e,7z,10e,13e,16e,19e)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(e)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate |
1-oleoyl-2-docosahexaenoylglycero-3-phosphorylcholine |
99296-82-9 |
1-odhpc |
3,5,8-trioxa-4-phosphatriaconta-12,15,18,21,24,27-hexaen-1-aminium, 4-hydroxy-n,n,n-trimethyl-9-oxo-7-(((1-oxo-9-octadecenyl)oxy)methyl)-, hydroxide, inner salt, 4-oxide, (r-(all-z))- |
1-oleoyl-2-dha-pc |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |